A double blind comparison of enzalutamide plus pembrolizumab or placebo in patients with metastatic prostate cancer.
Highlands Ranch Hospital
University of Colorado Hospital
Thomas Flaig, MD
Protocol Number: 19-0493
More information available at ClinicalTrials.gov: NCT03834493
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers